

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | indole-containing compound catabolic process (GO:0042436) | 4.62643571 |
| 2 | indolalkylamine catabolic process (GO:0046218) | 4.62643571 |
| 3 | tryptophan catabolic process (GO:0006569) | 4.62643571 |
| 4 | regulation of mitochondrial translation (GO:0070129) | 4.55631100 |
| 5 | tryptophan metabolic process (GO:0006568) | 4.42940982 |
| 6 | folic acid transport (GO:0015884) | 4.42044421 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.34340388 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.29484624 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.29484624 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.16621273 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 4.16621273 |
| 12 | GDP-mannose metabolic process (GO:0019673) | 4.12874962 |
| 13 | rRNA modification (GO:0000154) | 3.98633784 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 3.96884125 |
| 15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.95108770 |
| 16 | indolalkylamine metabolic process (GO:0006586) | 3.87687887 |
| 17 | glycine metabolic process (GO:0006544) | 3.84104700 |
| 18 | rRNA methylation (GO:0031167) | 3.81891249 |
| 19 | kynurenine metabolic process (GO:0070189) | 3.80116526 |
| 20 | ATP synthesis coupled proton transport (GO:0015986) | 3.79282155 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.79282155 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 3.73378116 |
| 23 | sequestering of actin monomers (GO:0042989) | 3.61658134 |
| 24 | NADH metabolic process (GO:0006734) | 3.61400041 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.60410497 |
| 26 | regulation of oxidative phosphorylation (GO:0002082) | 3.59299483 |
| 27 | oligosaccharide catabolic process (GO:0009313) | 3.51939805 |
| 28 | ethanol oxidation (GO:0006069) | 3.50577742 |
| 29 | glyoxylate metabolic process (GO:0046487) | 3.50264029 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 3.50136317 |
| 31 | serine family amino acid biosynthetic process (GO:0009070) | 3.48667591 |
| 32 | oxaloacetate metabolic process (GO:0006107) | 3.47398060 |
| 33 | viral transcription (GO:0019083) | 3.47068724 |
| 34 | DNA deamination (GO:0045006) | 3.44582977 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 3.38680507 |
| 36 | serine family amino acid metabolic process (GO:0009069) | 3.38654226 |
| 37 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.35288959 |
| 38 | cysteine metabolic process (GO:0006534) | 3.34367767 |
| 39 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.34013223 |
| 40 | L-methionine salvage (GO:0071267) | 3.31109866 |
| 41 | L-methionine biosynthetic process (GO:0071265) | 3.31109866 |
| 42 | amino acid salvage (GO:0043102) | 3.31109866 |
| 43 | proline metabolic process (GO:0006560) | 3.30779339 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 3.30485207 |
| 45 | cellular biogenic amine catabolic process (GO:0042402) | 3.28545422 |
| 46 | amine catabolic process (GO:0009310) | 3.28545422 |
| 47 | basic amino acid transport (GO:0015802) | 3.28219424 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 3.28040968 |
| 49 | ribosomal small subunit assembly (GO:0000028) | 3.24463297 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.23652627 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 3.22375139 |
| 52 | imidazole-containing compound metabolic process (GO:0052803) | 3.20935198 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16343289 |
| 54 | NAD biosynthetic process (GO:0009435) | 3.16328977 |
| 55 | urea metabolic process (GO:0019627) | 3.16312957 |
| 56 | urea cycle (GO:0000050) | 3.16312957 |
| 57 | amino sugar catabolic process (GO:0046348) | 3.16302472 |
| 58 | folic acid metabolic process (GO:0046655) | 3.13655892 |
| 59 | NAD metabolic process (GO:0019674) | 3.12896339 |
| 60 | regulation of cholesterol esterification (GO:0010872) | 3.12419927 |
| 61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.12130218 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.12130218 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.12130218 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 3.12130218 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 3.12130218 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 3.12130218 |
| 67 | translational termination (GO:0006415) | 3.10652165 |
| 68 | proteasome assembly (GO:0043248) | 3.10053145 |
| 69 | interferon-gamma production (GO:0032609) | 3.09546559 |
| 70 | respiratory electron transport chain (GO:0022904) | 3.08721741 |
| 71 | indole-containing compound metabolic process (GO:0042430) | 3.08631993 |
| 72 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.08354977 |
| 73 | viral protein processing (GO:0019082) | 3.08169838 |
| 74 | protein targeting to ER (GO:0045047) | 3.07351174 |
| 75 | positive regulation of protein homooligomerization (GO:0032464) | 3.05234946 |
| 76 | DNA double-strand break processing (GO:0000729) | 3.05204466 |
| 77 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.04754558 |
| 78 | detection of bacterium (GO:0016045) | 3.02056453 |
| 79 | cotranslational protein targeting to membrane (GO:0006613) | 3.01749682 |
| 80 | response to interferon-beta (GO:0035456) | 3.01405252 |
| 81 | protein complex biogenesis (GO:0070271) | 3.00356489 |
| 82 | electron transport chain (GO:0022900) | 3.00184300 |
| 83 | amino-acid betaine metabolic process (GO:0006577) | 2.99815901 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 2.99490386 |
| 85 | negative regulation of sterol transport (GO:0032372) | 2.99490386 |
| 86 | cytochrome complex assembly (GO:0017004) | 2.98886138 |
| 87 | coenzyme catabolic process (GO:0009109) | 2.98666212 |
| 88 | sulfur amino acid biosynthetic process (GO:0000097) | 2.96998242 |
| 89 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96980288 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 2.96362521 |
| 91 | leukocyte aggregation (GO:0070486) | 2.95809951 |
| 92 | protein localization to endoplasmic reticulum (GO:0070972) | 2.95765905 |
| 93 | L-serine metabolic process (GO:0006563) | 2.95127547 |
| 94 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.94866746 |
| 95 | proline biosynthetic process (GO:0006561) | 2.93804446 |
| 96 | translational elongation (GO:0006414) | 2.93547414 |
| 97 | nitrogen cycle metabolic process (GO:0071941) | 2.92683726 |
| 98 | methionine metabolic process (GO:0006555) | 2.91888454 |
| 99 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.90361676 |
| 100 | cellular response to interferon-beta (GO:0035458) | 2.89830786 |
| 101 | cellular response to interleukin-15 (GO:0071350) | 2.87795852 |
| 102 | pseudouridine synthesis (GO:0001522) | 2.86890229 |
| 103 | nucleobase biosynthetic process (GO:0046112) | 2.86363339 |
| 104 | response to peptidoglycan (GO:0032494) | 2.85951295 |
| 105 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.85753996 |
| 106 | formation of translation preinitiation complex (GO:0001731) | 2.85423645 |
| 107 | lysine metabolic process (GO:0006553) | 2.85213143 |
| 108 | lysine catabolic process (GO:0006554) | 2.85213143 |
| 109 | bile acid biosynthetic process (GO:0006699) | 2.84216514 |
| 110 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.83913597 |
| 111 | negative regulation of interleukin-12 production (GO:0032695) | 2.83723069 |
| 112 | fatty acid homeostasis (GO:0055089) | 2.82663162 |
| 113 | cellular response to type I interferon (GO:0071357) | 2.81642063 |
| 114 | type I interferon signaling pathway (GO:0060337) | 2.81642063 |
| 115 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.81541205 |
| 116 | homocysteine metabolic process (GO:0050667) | 2.81485771 |
| 117 | regulation of protein activation cascade (GO:2000257) | 2.80358840 |
| 118 | sulfur amino acid metabolic process (GO:0000096) | 2.79775838 |
| 119 | GTP biosynthetic process (GO:0006183) | 2.79658928 |
| 120 | complement activation, classical pathway (GO:0006958) | 2.77727615 |
| 121 | vitamin transport (GO:0051180) | 2.77622747 |
| 122 | B cell mediated immunity (GO:0019724) | 2.77259877 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.76783469 |
| 124 | UTP biosynthetic process (GO:0006228) | 2.76424237 |
| 125 | negative regulation of cell killing (GO:0031342) | 2.75738614 |
| 126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.75738614 |
| 127 | response to type I interferon (GO:0034340) | 2.74573056 |
| 128 | tRNA methylation (GO:0030488) | 2.72636612 |
| 129 | detection of other organism (GO:0098543) | 2.71739408 |
| 130 | ribosome biogenesis (GO:0042254) | 2.70575713 |
| 131 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.69435699 |
| 132 | viral life cycle (GO:0019058) | 2.69105226 |
| 133 | drug transport (GO:0015893) | 2.69006368 |
| 134 | negative regulation of innate immune response (GO:0045824) | 2.66956636 |
| 135 | fructose metabolic process (GO:0006000) | 2.66089010 |
| 136 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.65856558 |
| 137 | regulation of hypersensitivity (GO:0002883) | 2.65703241 |
| 138 | regulation of T cell tolerance induction (GO:0002664) | 2.65229879 |
| 139 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.64200833 |
| 140 | ribosomal small subunit biogenesis (GO:0042274) | 2.64169008 |
| 141 | mast cell activation involved in immune response (GO:0002279) | 2.63620065 |
| 142 | mast cell degranulation (GO:0043303) | 2.63620065 |
| 143 | macrophage activation involved in immune response (GO:0002281) | 2.63531574 |
| 144 | urate metabolic process (GO:0046415) | 2.63426955 |
| 145 | reverse cholesterol transport (GO:0043691) | 2.62580445 |
| 146 | 2-oxoglutarate metabolic process (GO:0006103) | 2.62239708 |
| 147 | mitochondrial DNA replication (GO:0006264) | 2.61889729 |
| 148 | purine nucleobase biosynthetic process (GO:0009113) | 2.61833992 |
| 149 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.61796491 |
| 150 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.61033528 |
| 151 | mast cell activation (GO:0045576) | 2.60890108 |
| 152 | regulation of complement activation (GO:0030449) | 2.60768025 |
| 153 | respiratory burst (GO:0045730) | 2.60618737 |
| 154 | glucosamine-containing compound catabolic process (GO:1901072) | 2.60545092 |
| 155 | drug transmembrane transport (GO:0006855) | 2.59613033 |
| 156 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.58321759 |
| 157 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.58321759 |
| 158 | regulation of antigen processing and presentation (GO:0002577) | 2.57821480 |
| 159 | low-density lipoprotein particle remodeling (GO:0034374) | 2.57472423 |
| 160 | lymphocyte chemotaxis (GO:0048247) | 2.56813836 |
| 161 | regulation of bile acid biosynthetic process (GO:0070857) | 2.56272124 |
| 162 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.56006518 |
| 163 | methionine biosynthetic process (GO:0009086) | 2.55976765 |
| 164 | phospholipid efflux (GO:0033700) | 2.54505102 |
| 165 | valine metabolic process (GO:0006573) | 2.54245298 |
| 166 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.53659082 |
| 167 | cofactor catabolic process (GO:0051187) | 2.53158176 |
| 168 | negative regulation of fibrinolysis (GO:0051918) | 2.52697566 |
| 169 | mannose metabolic process (GO:0006013) | 2.52540823 |
| 170 | myeloid dendritic cell activation (GO:0001773) | 2.50687046 |
| 171 | regulation of superoxide anion generation (GO:0032928) | 2.50293471 |
| 172 | UTP metabolic process (GO:0046051) | 2.49706814 |
| 173 | virion assembly (GO:0019068) | 2.47980567 |
| 174 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.47447607 |
| 175 | maturation of SSU-rRNA (GO:0030490) | 2.46269581 |
| 176 | GMP metabolic process (GO:0046037) | 2.43996990 |
| 177 | negative regulation of phagocytosis (GO:0050765) | 2.40969792 |
| 178 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.39758468 |
| 179 | mannosylation (GO:0097502) | 2.39362808 |
| 180 | T cell migration (GO:0072678) | 2.38745089 |
| 181 | pentose metabolic process (GO:0019321) | 2.38336252 |
| 182 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.36901730 |
| 183 | response to host immune response (GO:0052572) | 2.36349010 |
| 184 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.36349010 |
| 185 | pyrimidine nucleoside salvage (GO:0043097) | 2.36137199 |
| 186 | pyrimidine-containing compound salvage (GO:0008655) | 2.36137199 |
| 187 | positive regulation of antigen processing and presentation (GO:0002579) | 2.35525715 |
| 188 | negative thymic T cell selection (GO:0045060) | 2.34560955 |
| 189 | base-excision repair, AP site formation (GO:0006285) | 2.34107248 |
| 190 | hydrogen ion transmembrane transport (GO:1902600) | 2.33360567 |
| 191 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.31033337 |
| 192 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.30637236 |
| 193 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.30575380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.82225764 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.58209808 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.28676225 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.05175480 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.76713366 |
| 6 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.72211267 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.67126956 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.66977245 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59380085 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.59315986 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.54846171 |
| 12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.54102507 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.53291447 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.44414752 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.43145802 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.38696902 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.35507953 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.35417018 |
| 19 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.33127374 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.25465656 |
| 21 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.21877285 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20406428 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.18134395 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16686738 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.14804676 |
| 26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.14780224 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.08971372 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.08776801 |
| 29 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.05925515 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.04401225 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.03372548 |
| 32 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.03009278 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.01982606 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.00649137 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95183154 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.93580743 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.93573017 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.93117352 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92012061 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.88949734 |
| 41 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82064482 |
| 42 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.81888055 |
| 43 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79222847 |
| 44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78694609 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.78091307 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72654671 |
| 47 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.72541399 |
| 48 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.72541399 |
| 49 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.72541399 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.72003824 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70855124 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67546297 |
| 53 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64283976 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.62038681 |
| 55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.60619409 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60525689 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.59774044 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.59743547 |
| 59 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56672745 |
| 60 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56107833 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55850812 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.54298980 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53760901 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.52822808 |
| 65 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.52536901 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.52199448 |
| 67 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.51774527 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49611609 |
| 69 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.47985079 |
| 70 | * MAF_26560356_Chip-Seq_TH1_Human | 1.47435000 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44826084 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43670917 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.43489913 |
| 74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.42131483 |
| 75 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41440841 |
| 76 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40190210 |
| 77 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40011040 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 1.36684884 |
| 79 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.35586814 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35499326 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.35451790 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35082424 |
| 83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35076685 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32002377 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31319899 |
| 86 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27955473 |
| 87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27166443 |
| 88 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26711132 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26153160 |
| 90 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25409871 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25324643 |
| 92 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23873626 |
| 93 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23498974 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21917445 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.20732330 |
| 96 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.20353625 |
| 97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20330718 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19972300 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19903830 |
| 100 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.19693020 |
| 101 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.18687238 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17455251 |
| 103 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15788696 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15631836 |
| 105 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14690474 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14360584 |
| 107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13993323 |
| 108 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13426374 |
| 109 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12507539 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12468785 |
| 111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12007076 |
| 112 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11651193 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11405105 |
| 114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10781613 |
| 115 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10623318 |
| 116 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09216006 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09160007 |
| 118 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09130855 |
| 119 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08643527 |
| 120 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07969318 |
| 121 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.07886735 |
| 122 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07850784 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07721583 |
| 124 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07361607 |
| 125 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07107262 |
| 126 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06901352 |
| 127 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05786898 |
| 128 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05146052 |
| 129 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04856922 |
| 130 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04329767 |
| 131 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04260566 |
| 132 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04146807 |
| 133 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03910543 |
| 134 | P300_27268052_Chip-Seq_Bcells_Human | 1.03743180 |
| 135 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03619805 |
| 136 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.01971054 |
| 137 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01608025 |
| 138 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.01444000 |
| 139 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00122106 |
| 140 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98959243 |
| 141 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97997501 |
| 142 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97245325 |
| 143 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.96894855 |
| 144 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96520570 |
| 145 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94827063 |
| 146 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.94141253 |
| 147 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93772851 |
| 148 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92516775 |
| 149 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91957360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.51342388 |
| 2 | MP0005360_urolithiasis | 4.29575543 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.10550238 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.64084401 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.57906158 |
| 6 | MP0005365_abnormal_bile_salt | 3.55331547 |
| 7 | MP0009840_abnormal_foam_cell | 2.61914588 |
| 8 | MP0002822_catalepsy | 2.38766373 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.37555652 |
| 10 | MP0005332_abnormal_amino_acid | 2.33810934 |
| 11 | MP0001764_abnormal_homeostasis | 2.32762326 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.26367011 |
| 13 | MP0005451_abnormal_body_composition | 2.14745394 |
| 14 | MP0002132_abnormal_respiratory_system | 2.04539620 |
| 15 | MP0005671_abnormal_response_to | 2.01358006 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 1.98576845 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 1.98101885 |
| 18 | MP0003195_calcinosis | 1.93619562 |
| 19 | MP0004510_myositis | 1.92768988 |
| 20 | MP0009697_abnormal_copulation | 1.90188232 |
| 21 | MP0003436_decreased_susceptibility_to | 1.87843217 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.87073627 |
| 23 | MP0006292_abnormal_olfactory_placode | 1.86022625 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.77760840 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.68106667 |
| 26 | MP0008260_abnormal_autophagy | 1.67373151 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.64933524 |
| 28 | MP0000566_synostosis | 1.59547733 |
| 29 | MP0005310_abnormal_salivary_gland | 1.58725465 |
| 30 | MP0003186_abnormal_redox_activity | 1.57497916 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.57217835 |
| 32 | MP0000609_abnormal_liver_physiology | 1.56961742 |
| 33 | MP0003303_peritoneal_inflammation | 1.55356312 |
| 34 | MP0006082_CNS_inflammation | 1.53212571 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.50052504 |
| 36 | MP0001800_abnormal_humoral_immune | 1.49193394 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.48759297 |
| 38 | MP0000685_abnormal_immune_system | 1.42095192 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.40631105 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.40049988 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.39929645 |
| 42 | MP0002405_respiratory_system_inflammati | 1.37905038 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.36900988 |
| 44 | MP0009785_altered_susceptibility_to | 1.35982651 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.32735143 |
| 46 | MP0004947_skin_inflammation | 1.30510837 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.29837664 |
| 48 | MP0003075_altered_response_to | 1.26524379 |
| 49 | MP0008872_abnormal_physiological_respon | 1.26375600 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.25974570 |
| 51 | MP0008058_abnormal_DNA_repair | 1.25546680 |
| 52 | MP0005083_abnormal_biliary_tract | 1.24448577 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24411392 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.23762927 |
| 55 | MP0003252_abnormal_bile_duct | 1.23285802 |
| 56 | MP0008469_abnormal_protein_level | 1.22609923 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.19548396 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.18907152 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.18704102 |
| 60 | MP0003866_abnormal_defecation | 1.18328673 |
| 61 | MP0002723_abnormal_immune_serum | 1.17720625 |
| 62 | MP0001873_stomach_inflammation | 1.17068809 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.16479684 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.15074032 |
| 65 | * MP0002398_abnormal_bone_marrow | 1.14526659 |
| 66 | MP0002722_abnormal_immune_system | 1.13964523 |
| 67 | MP0001666_abnormal_nutrient_absorption | 1.12153402 |
| 68 | MP0010094_abnormal_chromosome_stability | 1.12128771 |
| 69 | MP0009764_decreased_sensitivity_to | 1.11243507 |
| 70 | MP0005000_abnormal_immune_tolerance | 1.10359316 |
| 71 | MP0005025_abnormal_response_to | 1.10337971 |
| 72 | MP0002163_abnormal_gland_morphology | 1.09306372 |
| 73 | MP0001853_heart_inflammation | 1.06976636 |
| 74 | * MP0002420_abnormal_adaptive_immunity | 1.06604919 |
| 75 | * MP0001819_abnormal_immune_cell | 1.04949775 |
| 76 | MP0009278_abnormal_bone_marrow | 1.04589835 |
| 77 | MP0003718_maternal_effect | 1.04002384 |
| 78 | MP0001790_abnormal_immune_system | 1.03973182 |
| 79 | MP0005387_immune_system_phenotype | 1.03973182 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.01206549 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.99652325 |
| 82 | MP0002452_abnormal_antigen_presenting | 0.99316705 |
| 83 | MP0003123_paternal_imprinting | 0.99187208 |
| 84 | MP0004381_abnormal_hair_follicle | 0.99160363 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.98628801 |
| 86 | MP0000716_abnormal_immune_system | 0.98209759 |
| 87 | MP0000358_abnormal_cell_content/ | 0.97715552 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 0.97631566 |
| 89 | MP0000598_abnormal_liver_morphology | 0.96348627 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.95940459 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.94537449 |
| 92 | MP0009763_increased_sensitivity_to | 0.93783187 |
| 93 | * MP0002429_abnormal_blood_cell | 0.93478065 |
| 94 | MP0000343_altered_response_to | 0.93077601 |
| 95 | MP0002419_abnormal_innate_immunity | 0.92978907 |
| 96 | MP0003122_maternal_imprinting | 0.92183476 |
| 97 | MP0002796_impaired_skin_barrier | 0.91951574 |
| 98 | MP0000490_abnormal_crypts_of | 0.90823591 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.90352640 |
| 100 | MP0003077_abnormal_cell_cycle | 0.90339084 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 0.89824996 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.89824996 |
| 103 | MP0002148_abnormal_hypersensitivity_rea | 0.89781001 |
| 104 | MP0002254_reproductive_system_inflammat | 0.89267174 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.88632162 |
| 106 | MP0008057_abnormal_DNA_replication | 0.87856355 |
| 107 | MP0005390_skeleton_phenotype | 0.87141018 |
| 108 | MP0000604_amyloidosis | 0.87121649 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.87106863 |
| 110 | MP0000858_altered_metastatic_potential | 0.87027105 |
| 111 | MP0005670_abnormal_white_adipose | 0.86610836 |
| 112 | MP0003879_abnormal_hair_cell | 0.86601174 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.86120919 |
| 114 | MP0005166_decreased_susceptibility_to | 0.85721369 |
| 115 | * MP0009642_abnormal_blood_homeostasis | 0.85597136 |
| 116 | MP0002736_abnormal_nociception_after | 0.83747886 |
| 117 | MP0009379_abnormal_foot_pigmentation | 0.83369413 |
| 118 | MP0003111_abnormal_nucleus_morphology | 0.82907588 |
| 119 | MP0008007_abnormal_cellular_replicative | 0.82637166 |
| 120 | MP0002933_joint_inflammation | 0.82231927 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.81829778 |
| 122 | MP0004133_heterotaxia | 0.81776324 |
| 123 | MP0004742_abnormal_vestibular_system | 0.79491095 |
| 124 | MP0001968_abnormal_touch/_nociception | 0.79022331 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.74898492 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.74696671 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.74122940 |
| 128 | MP0001756_abnormal_urination | 0.73961644 |
| 129 | MP0000538_abnormal_urinary_bladder | 0.73861818 |
| 130 | MP0003329_amyloid_beta_deposits | 0.73764871 |
| 131 | MP0005408_hypopigmentation | 0.73688881 |
| 132 | MP0005266_abnormal_metabolism | 0.73585676 |
| 133 | MP0003191_abnormal_cellular_cholesterol | 0.72404066 |
| 134 | MP0001216_abnormal_epidermal_layer | 0.72206002 |
| 135 | MP0003724_increased_susceptibility_to | 0.72023039 |
| 136 | MP0004142_abnormal_muscle_tone | 0.71977547 |
| 137 | MP0001727_abnormal_embryo_implantation | 0.70567616 |
| 138 | MP0002928_abnormal_bile_duct | 0.69663824 |
| 139 | MP0003448_altered_tumor_morphology | 0.69410934 |
| 140 | MP0000678_abnormal_parathyroid_gland | 0.67640659 |
| 141 | MP0005501_abnormal_skin_physiology | 0.65303584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.40773305 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.40773305 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.40773305 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.03045099 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.01857587 |
| 6 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.84775393 |
| 7 | Renal Fanconi syndrome (HP:0001994) | 3.63491737 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.61992524 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.52379735 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.44190158 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.41990301 |
| 12 | Increased intramyocellular lipid droplets (HP:0012240) | 3.41334784 |
| 13 | Hyperglycinemia (HP:0002154) | 3.37659821 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 3.27937463 |
| 15 | Hyperglycinuria (HP:0003108) | 3.22391765 |
| 16 | Increased muscle lipid content (HP:0009058) | 3.16673033 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.12987927 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.12893158 |
| 19 | Gout (HP:0001997) | 3.12525612 |
| 20 | Lipid accumulation in hepatocytes (HP:0006561) | 3.11710485 |
| 21 | Complement deficiency (HP:0004431) | 3.08918261 |
| 22 | Xanthomatosis (HP:0000991) | 3.00591190 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 2.98353457 |
| 24 | Recurrent abscess formation (HP:0002722) | 2.98349061 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.98329475 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 2.98329475 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95609084 |
| 28 | Obstructive lung disease (HP:0006536) | 2.93335608 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.93335608 |
| 30 | Hyperammonemia (HP:0001987) | 2.91881542 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.88514433 |
| 32 | Delayed CNS myelination (HP:0002188) | 2.82621904 |
| 33 | Exertional dyspnea (HP:0002875) | 2.78517329 |
| 34 | Abnormal number of erythroid precursors (HP:0012131) | 2.78093920 |
| 35 | IgM deficiency (HP:0002850) | 2.76297088 |
| 36 | Dry hair (HP:0011359) | 2.75845486 |
| 37 | Joint hemorrhage (HP:0005261) | 2.75309525 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.74149484 |
| 39 | Abnormality of the lower motor neuron (HP:0002366) | 2.70641432 |
| 40 | Acute necrotizing encephalopathy (HP:0006965) | 2.67729001 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.64432791 |
| 42 | Ketosis (HP:0001946) | 2.60679453 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.60140149 |
| 44 | Deep venous thrombosis (HP:0002625) | 2.58131400 |
| 45 | Aplastic anemia (HP:0001915) | 2.57855774 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.55422655 |
| 47 | Abnormality of complement system (HP:0005339) | 2.53326229 |
| 48 | Increased IgM level (HP:0003496) | 2.50993527 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48799446 |
| 50 | Stomatitis (HP:0010280) | 2.47984599 |
| 51 | Hyperlipoproteinemia (HP:0010980) | 2.47755667 |
| 52 | Lethargy (HP:0001254) | 2.47686725 |
| 53 | 3-Methylglutaconic aciduria (HP:0003535) | 2.46536614 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.45868967 |
| 55 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.45343605 |
| 56 | Progressive neurologic deterioration (HP:0002344) | 2.43911156 |
| 57 | Microvesicular hepatic steatosis (HP:0001414) | 2.42635978 |
| 58 | Hyperventilation (HP:0002883) | 2.41620386 |
| 59 | Myositis (HP:0100614) | 2.41587947 |
| 60 | Meningitis (HP:0001287) | 2.40260888 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.40239618 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.40187367 |
| 63 | Recurrent skin infections (HP:0001581) | 2.39700633 |
| 64 | Abnormality of methionine metabolism (HP:0010901) | 2.39389434 |
| 65 | Ragged-red muscle fibers (HP:0003200) | 2.35828825 |
| 66 | Upper motor neuron abnormality (HP:0002127) | 2.32150937 |
| 67 | Purpura (HP:0000979) | 2.31816526 |
| 68 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.27884991 |
| 69 | Increased serum ferritin (HP:0003281) | 2.27260685 |
| 70 | Abnormality of serum amino acid levels (HP:0003112) | 2.27205276 |
| 71 | Glomerulonephritis (HP:0000099) | 2.27038052 |
| 72 | Metabolic acidosis (HP:0001942) | 2.26397596 |
| 73 | Respiratory difficulties (HP:0002880) | 2.22590162 |
| 74 | Exercise intolerance (HP:0003546) | 2.21840420 |
| 75 | Hyperbilirubinemia (HP:0002904) | 2.20675972 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19611690 |
| 77 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.18532527 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.18170533 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18170533 |
| 80 | Opisthotonus (HP:0002179) | 2.16825701 |
| 81 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16474529 |
| 82 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16474529 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16474529 |
| 84 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16197737 |
| 85 | Cerebral edema (HP:0002181) | 2.16103396 |
| 86 | Increased serum lactate (HP:0002151) | 2.14349844 |
| 87 | Megaloblastic anemia (HP:0001889) | 2.13343900 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.13284104 |
| 89 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.13022918 |
| 90 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.13022918 |
| 91 | Ketoacidosis (HP:0001993) | 2.12683343 |
| 92 | Late onset (HP:0003584) | 2.09870021 |
| 93 | Lactic acidosis (HP:0003128) | 2.09370549 |
| 94 | Vasculitis (HP:0002633) | 2.08845658 |
| 95 | Oral leukoplakia (HP:0002745) | 2.08384957 |
| 96 | Pulmonary fibrosis (HP:0002206) | 2.06739303 |
| 97 | Abnormality of the common coagulation pathway (HP:0010990) | 2.06315201 |
| 98 | Increased purine levels (HP:0004368) | 2.06010371 |
| 99 | Hyperuricemia (HP:0002149) | 2.06010371 |
| 100 | Progressive macrocephaly (HP:0004481) | 2.05220699 |
| 101 | Type I transferrin isoform profile (HP:0003642) | 2.04516113 |
| 102 | Pancytopenia (HP:0001876) | 2.03222176 |
| 103 | Thyroid-stimulating hormone excess (HP:0002925) | 2.02853077 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 2.02276650 |
| 105 | Fat malabsorption (HP:0002630) | 2.01674521 |
| 106 | Hepatic necrosis (HP:0002605) | 2.01549006 |
| 107 | Irritability (HP:0000737) | 2.01353590 |
| 108 | Anorexia (HP:0002039) | 2.01220563 |
| 109 | Recurrent fungal infections (HP:0002841) | 2.00728728 |
| 110 | Hepatocellular necrosis (HP:0001404) | 1.99247248 |
| 111 | Type 2 muscle fiber atrophy (HP:0003554) | 1.98684816 |
| 112 | Abnormality of purine metabolism (HP:0004352) | 1.97822526 |
| 113 | Renal tubular acidosis (HP:0001947) | 1.97554701 |
| 114 | Hypolipoproteinemia (HP:0010981) | 1.97319757 |
| 115 | Tongue fasciculations (HP:0001308) | 1.96764745 |
| 116 | Progressive muscle weakness (HP:0003323) | 1.96481477 |
| 117 | Urticaria (HP:0001025) | 1.96229002 |
| 118 | Acute encephalopathy (HP:0006846) | 1.95940095 |
| 119 | Respiratory failure (HP:0002878) | 1.95691845 |
| 120 | Poor suck (HP:0002033) | 1.95509101 |
| 121 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95384368 |
| 122 | Loss of speech (HP:0002371) | 1.93299715 |
| 123 | Generalized aminoaciduria (HP:0002909) | 1.92645600 |
| 124 | Joint swelling (HP:0001386) | 1.92574151 |
| 125 | Prolonged neonatal jaundice (HP:0006579) | 1.92327198 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 1.91587129 |
| 127 | Proximal tubulopathy (HP:0000114) | 1.91541420 |
| 128 | Petechiae (HP:0000967) | 1.91287560 |
| 129 | Reduced antithrombin III activity (HP:0001976) | 1.91002583 |
| 130 | Cerebral hypomyelination (HP:0006808) | 1.90424212 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.89849038 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.88269634 |
| 133 | Vomiting (HP:0002013) | 1.87663420 |
| 134 | Epiphyseal stippling (HP:0010655) | 1.86689921 |
| 135 | Hyperphosphaturia (HP:0003109) | 1.86413807 |
| 136 | Orchitis (HP:0100796) | 1.85819089 |
| 137 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.84291110 |
| 138 | Hepatosplenomegaly (HP:0001433) | 1.84197128 |
| 139 | Reticulocytopenia (HP:0001896) | 1.84160058 |
| 140 | Pulmonary infiltrates (HP:0002113) | 1.84122066 |
| 141 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83725100 |
| 142 | Hypertensive crisis (HP:0100735) | 1.83266184 |
| 143 | Emotional lability (HP:0000712) | 1.83217757 |
| 144 | Gangrene (HP:0100758) | 1.83093367 |
| 145 | Steatorrhea (HP:0002570) | 1.82767940 |
| 146 | Abnormality of renal resorption (HP:0011038) | 1.81927134 |
| 147 | Hypergammaglobulinemia (HP:0010702) | 1.81912837 |
| 148 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.81228611 |
| 149 | Muscle fibrillation (HP:0010546) | 1.80918722 |
| 150 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80416670 |
| 151 | Increased CSF lactate (HP:0002490) | 1.78075793 |
| 152 | Abnormality of lateral ventricle (HP:0030047) | 1.78017028 |
| 153 | Mucopolysacchariduria (HP:0008155) | 1.77894270 |
| 154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77894270 |
| 155 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77480755 |
| 156 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77480755 |
| 157 | Acute hepatic failure (HP:0006554) | 1.76875565 |
| 158 | Methylmalonic aciduria (HP:0012120) | 1.76672045 |
| 159 | Delusions (HP:0000746) | 1.75618437 |
| 160 | CNS demyelination (HP:0007305) | 1.74979831 |
| 161 | Retrobulbar optic neuritis (HP:0100654) | 1.74656329 |
| 162 | Optic neuritis (HP:0100653) | 1.74656329 |
| 163 | Agnosia (HP:0010524) | 1.73193915 |
| 164 | Impulsivity (HP:0100710) | 1.72503610 |
| 165 | Hypercholesterolemia (HP:0003124) | 1.72209960 |
| 166 | Brushfield spots (HP:0001088) | 1.71122330 |
| 167 | Hypoplasia of the thymus (HP:0000778) | 1.70653524 |
| 168 | Pustule (HP:0200039) | 1.68382548 |
| 169 | Mitochondrial inheritance (HP:0001427) | 1.68070615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 7.12323395 |
| 2 | VRK2 | 3.22949596 |
| 3 | TSSK6 | 3.22893910 |
| 4 | MAP4K1 | 2.98692686 |
| 5 | TXK | 2.79381757 |
| 6 | STK16 | 2.59918905 |
| 7 | IRAK3 | 2.46665460 |
| 8 | MAP3K10 | 2.39887270 |
| 9 | ERN1 | 2.26678548 |
| 10 | TESK1 | 2.18680843 |
| 11 | DAPK1 | 2.17846133 |
| 12 | BCKDK | 2.15398668 |
| 13 | MAP3K12 | 2.14750592 |
| 14 | TRIB3 | 2.13819389 |
| 15 | PRPF4B | 2.12523428 |
| 16 | SIK3 | 2.12149313 |
| 17 | BUB1 | 2.01042125 |
| 18 | PINK1 | 2.00439641 |
| 19 | RIPK4 | 1.97795538 |
| 20 | ICK | 1.95083589 |
| 21 | PLK4 | 1.85334946 |
| 22 | TLK1 | 1.81088938 |
| 23 | CASK | 1.80658459 |
| 24 | GRK6 | 1.78614916 |
| 25 | FGFR4 | 1.68876484 |
| 26 | SMG1 | 1.67067193 |
| 27 | AKT3 | 1.64810678 |
| 28 | CCNB1 | 1.62341559 |
| 29 | MAP3K11 | 1.55967683 |
| 30 | ZAP70 | 1.48687974 |
| 31 | MAP2K3 | 1.47018898 |
| 32 | MAP2K6 | 1.42203160 |
| 33 | BTK | 1.41330181 |
| 34 | MAP2K2 | 1.36913985 |
| 35 | EPHB1 | 1.35870863 |
| 36 | WEE1 | 1.29684916 |
| 37 | EPHA4 | 1.27782790 |
| 38 | MAP2K7 | 1.26290147 |
| 39 | LMTK2 | 1.25317603 |
| 40 | ADRBK2 | 1.21934627 |
| 41 | PDK3 | 1.18501611 |
| 42 | PDK4 | 1.18501611 |
| 43 | VRK1 | 1.17798734 |
| 44 | GRK7 | 1.15126909 |
| 45 | IRAK4 | 1.10584948 |
| 46 | MST4 | 1.08355862 |
| 47 | MAP3K14 | 1.08341701 |
| 48 | TYK2 | 1.07995389 |
| 49 | NME1 | 1.06646863 |
| 50 | PASK | 1.05151759 |
| 51 | EPHA2 | 1.04575030 |
| 52 | KIT | 1.02265250 |
| 53 | PIM2 | 0.99287946 |
| 54 | EIF2AK1 | 0.97939343 |
| 55 | DAPK2 | 0.97039398 |
| 56 | LRRK2 | 0.91924966 |
| 57 | YES1 | 0.91564706 |
| 58 | NEK1 | 0.91069946 |
| 59 | ARAF | 0.90362068 |
| 60 | IKBKE | 0.85121497 |
| 61 | MAP2K4 | 0.84696012 |
| 62 | TEC | 0.84057942 |
| 63 | TAOK2 | 0.83823880 |
| 64 | ABL2 | 0.83190158 |
| 65 | SYK | 0.80880382 |
| 66 | MAPKAPK3 | 0.80766681 |
| 67 | MARK3 | 0.80006196 |
| 68 | SRPK1 | 0.77427923 |
| 69 | ACVR1B | 0.77069550 |
| 70 | KDR | 0.75471707 |
| 71 | ILK | 0.75044356 |
| 72 | TESK2 | 0.74568950 |
| 73 | MAP3K1 | 0.73086827 |
| 74 | SIK2 | 0.72455095 |
| 75 | PRKCI | 0.69910228 |
| 76 | TAOK1 | 0.69741250 |
| 77 | TAOK3 | 0.68681422 |
| 78 | TBK1 | 0.68328247 |
| 79 | NLK | 0.68122335 |
| 80 | IRAK1 | 0.67589230 |
| 81 | PRKG2 | 0.67346737 |
| 82 | RPS6KC1 | 0.64856573 |
| 83 | RPS6KL1 | 0.64856573 |
| 84 | DYRK3 | 0.64750425 |
| 85 | BRAF | 0.63857297 |
| 86 | JAK3 | 0.63204222 |
| 87 | BLK | 0.62317825 |
| 88 | HIPK2 | 0.61925621 |
| 89 | TNK2 | 0.61523577 |
| 90 | FLT3 | 0.59480283 |
| 91 | LYN | 0.58686435 |
| 92 | MAPK4 | 0.57742569 |
| 93 | HCK | 0.57403861 |
| 94 | NTRK3 | 0.57240419 |
| 95 | NME2 | 0.56963563 |
| 96 | IKBKB | 0.56741475 |
| 97 | MAPKAPK2 | 0.55607370 |
| 98 | CSF1R | 0.55496592 |
| 99 | MYLK | 0.55449395 |
| 100 | MAPK7 | 0.55270957 |
| 101 | MAPK11 | 0.55104920 |
| 102 | LCK | 0.54865155 |
| 103 | CDK7 | 0.54683574 |
| 104 | FES | 0.54482488 |
| 105 | RPS6KA5 | 0.54318937 |
| 106 | FGR | 0.54275716 |
| 107 | PHKG1 | 0.54224924 |
| 108 | PHKG2 | 0.54224924 |
| 109 | PTK2B | 0.53487319 |
| 110 | BRSK2 | 0.53323781 |
| 111 | ITK | 0.52459900 |
| 112 | PRKD2 | 0.51605759 |
| 113 | PDPK1 | 0.51589586 |
| 114 | PDK2 | 0.51032467 |
| 115 | CDC42BPA | 0.50688367 |
| 116 | SGK2 | 0.49396773 |
| 117 | DAPK3 | 0.48216485 |
| 118 | PTK6 | 0.48163134 |
| 119 | LIMK1 | 0.46839529 |
| 120 | EIF2AK3 | 0.46818109 |
| 121 | RPS6KA6 | 0.45530298 |
| 122 | PAK4 | 0.44329908 |
| 123 | MAPK12 | 0.44167750 |
| 124 | RPS6KA2 | 0.43525072 |
| 125 | PRKCG | 0.42873889 |
| 126 | PRKCD | 0.42707672 |
| 127 | PIM1 | 0.41735224 |
| 128 | FGFR3 | 0.41685320 |
| 129 | CDK8 | 0.40313138 |
| 130 | SGK3 | 0.39582029 |
| 131 | RPS6KA1 | 0.38998861 |
| 132 | PDK1 | 0.38941905 |
| 133 | PIK3CG | 0.38660285 |
| 134 | PLK1 | 0.38472154 |
| 135 | MAPK15 | 0.38361789 |
| 136 | JAK1 | 0.37241566 |
| 137 | STK10 | 0.36174991 |
| 138 | WNK3 | 0.34773280 |
| 139 | MAP3K4 | 0.33748150 |
| 140 | MAP3K3 | 0.33543394 |
| 141 | CSK | 0.33527460 |
| 142 | MATK | 0.32385649 |
| 143 | CSNK2A1 | 0.31106462 |
| 144 | CHUK | 0.30899538 |
| 145 | ZAK | 0.30442735 |
| 146 | BRSK1 | 0.29799557 |
| 147 | SIK1 | 0.29088645 |
| 148 | INSRR | 0.26931925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08848344 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.81611336 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.68723060 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66510455 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.61741191 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56409767 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.47173485 |
| 8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.39954860 |
| 9 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.32532298 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.32200732 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.27756073 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.20681873 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.10525052 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.07599738 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02353541 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.99334246 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.99133714 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98130819 |
| 19 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.94138917 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.93629476 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.91518661 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.90761464 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89511463 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87233081 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86701457 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.83709313 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.81167723 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.78292345 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.76708292 |
| 30 | Mismatch repair_Homo sapiens_hsa03430 | 1.75001655 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.74130618 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.71537791 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.71407339 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.71014087 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70668704 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69018326 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.63027547 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62561627 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61298100 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59768297 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.58936499 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57728501 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.57425513 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 1.53188026 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50295948 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47595882 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.45225519 |
| 48 | Protein export_Homo sapiens_hsa03060 | 1.43987959 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43539143 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.42355447 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42255942 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41092567 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36437577 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31798507 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30795931 |
| 56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.28813064 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 1.26789781 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24888229 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23166806 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21957683 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20240792 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.20188619 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20006646 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18641444 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16674092 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13656423 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13076763 |
| 68 | Ribosome_Homo sapiens_hsa03010 | 1.12658131 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.09541356 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09228192 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 1.05329493 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04446559 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04016473 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.02406170 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 1.02281093 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02104426 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01291792 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99550177 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99003749 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.98941178 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96436192 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96309406 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95688066 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94171041 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92301761 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91343269 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.88840021 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.86416092 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84147916 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82436004 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.82227179 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79745739 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.77574899 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76850127 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.76338724 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.76017854 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73725437 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72313933 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72193357 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.69116002 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67945620 |
| 102 | RNA transport_Homo sapiens_hsa03013 | 0.67460972 |
| 103 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66499187 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66123066 |
| 105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65116466 |
| 106 | RNA degradation_Homo sapiens_hsa03018 | 0.64464397 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.63887861 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.61996444 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59526783 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58849470 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58041388 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57016239 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55283685 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55241476 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55172780 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55023515 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53975608 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53933555 |
| 119 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53345319 |
| 120 | Homologous recombination_Homo sapiens_hsa03440 | 0.51797861 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51161235 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50302462 |
| 123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49609695 |
| 124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49373721 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.48105934 |
| 126 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47459893 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46577800 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44457845 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42450674 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41520888 |
| 131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41096755 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40813446 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40668388 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39210118 |
| 135 | Malaria_Homo sapiens_hsa05144 | 0.38847983 |
| 136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38328915 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36762345 |
| 138 | Hepatitis C_Homo sapiens_hsa05160 | 0.35933206 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35208344 |
| 140 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34749323 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34445614 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.34025047 |
| 143 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31517202 |
| 144 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31413052 |
| 145 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.31282001 |
| 146 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31197268 |
| 147 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29971945 |
| 148 | Apoptosis_Homo sapiens_hsa04210 | 0.29939220 |
| 149 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28102490 |
| 150 | Basal transcription factors_Homo sapiens_hsa03022 | 0.26552266 |
| 151 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.26483743 |
| 152 | Lysosome_Homo sapiens_hsa04142 | 0.26375243 |
| 153 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25819788 |
| 154 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22913053 |
| 155 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.19856392 |

